Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
IntelliPharmaCeutics International (IPCI) PT Lowered to $2 at Maxim Group, Still Has 'Hope'
-
Arlington Asset Investment (AI) PT Lowered to $14 at Maxim Group; Reiterates Buy
-
Seagate Technology (STX) PT Lowered to $38 at Maxim Group
-
Chipotle Mexican Grill (CMG) PT Lowered to $435 at Maxim Group
-
Nasdaq Approves Listing of Biometric Software and Hardware Solutions Provider, BIO-key International, Starting Tuesday, July 25, 2017
-
Maxim Group Downgrades Potbelly Corp (PBPB) to Hold
-
Q2 PIPE Market Slows Slightly, Hovering at the $20B Mark, as Heights Capital, Latham & Watkins, Kirkland & Ellis Lead Way
-
Inovio Pharma (INO) Prices 12.5M Shares at $6
-
Inovio Announces Pricing of Public Offering of Common Stock
-
Vertex (VRTX) PT Raised to $195 at Maxim Group
-
UPDATE: AEterna Zentaris (AEZs) PT Raised to $4 at Maxim Group; Macrilen Could Become the New Standard
-
NASDAQ Listed MYnd Analytics Inc. Announces Closing of $8.79 Million Public Offering
-
Pre-Open Stock Movers 07/19: (AEZS) (VRTX) (SNI) Higher; (DRYS) (NTRS) (HDP) Lower (more...)
-
StreetInsider Premium Hot Research Recap 7/19
-
UPDATE: Maxim Group Starts xG Technology, Inc. (XGTI) at Buy
-
Abeona Therapeutics (ABEO) PT Raised to $17 at Maxim Group
-
StreetInsider Premium Hot Research Notes Recap 7/18
-
Maxim Group Upgrades Chipotle Mexican Grill (CMG) to Buy
-
ImmunoCellular Therapeutics (IMUC) Prices Offering of Convertible Preferred Stock and Warrants
-
ImmunoCellular Therapeutics Announces Pricing of Public Offering of Convertible Preferred Stock and Warrants
-
First Republic Bank (FRC) PT Raised to $110 at Maxim Group
-
Trovagene (TROV) Reports $7.1M Direct Offering of Common Stock, Warrants
-
Trovagene Announces $7.1 Million Registered Direct Offering
-
MYnd Analytics Announces Uplisting to NASDAQ and Pricing of $8.79M Underwritten Offering
-
Maxim Group Maintains Sell on National Beverage (FIZZ) Despite 'In-Line' Results
-
Maxim Group Downgrades Kite Pharma (KITE) to Hold
-
UPDATE: Maxim Group Upgrades Hain Celestial (HAIN) to Buy
-
Cutera (CUTR) PT Raised to $33 at Maxim Group
-
Maxim Group Starts Bio-Key International (BKYI) at Buy
-
PlacementTracker Publishes First Half 2017 PIPE Market League Tables
-
Maxim Group Starts Elevate Credit Inc (ELVT) at Buy
-
Maxim Group Starts Enova International (ENVA) at Buy
-
NXT-ID (NXTD) Announces $3.43M Registered Direct Offering and Concurrent Private Placement of Common Stock, Warrants
-
NXT-ID Announces $3,432,000 Registered Direct Offering and Concurrent Private Placement
-
BeiGene, Ltd. (BGNE) PT Raised to $73 at Maxim Group; Positive on Celgene Deal
-
Seanergy Maritime Holdings Corp. Reports Financial Results for the Quarter Ended March 31, 2017
-
Prima BioMed (PBMD) Announces Pricing of $5M Registered Direct Offering of ADSs
-
Prima BioMed Announces Pricing of US$5.0 Million Registered Direct Offering of Its American Depositary Shares
-
Seanergy Maritime Holdings Corp. Announces Termination of its "At-The-Market" Equity Offering Program
-
Michael Frankel Joins HilltopSecurities’ Capital Markets
-
Maxim Group Starts Good Times Restaurants (GTIM) at Buy
-
Maxim Group Starts Del Taco Restaurants (TACO) at Buy
-
Interpace Diagnostics Announces Closing of $13.7 Million Public Offering
-
Maxim Group Reiterates Hold on Chipotle Mexican Grill (CMG)
-
UPDATE: Maxim Group Upgrades Pluristem Therapeutics (PSTI) to Buy
-
Apple (AAPL) PT Raised to $180 at Maxim Group, Raises FY18 EPS Estimate To Street High
-
UPDATE: Maxim Group Downgrades Wayfair (W) to Hold
-
Interpace Diagnostics (IDXG) Prices 12.5M Share Common Offering at $1.10/Sh
-
Interpace Diagnostics Announces Pricing of $13.7 Million Underwritten Public Offering of Common Stock and Common Warrants
-
Viking Therapeutics (VKTX) Enters $4.3M Registered Direct Offering


